Source data are provided with the article: Inhalable nanovesicles loaded with a STING agonist enhance CAR-T cell activity against solid tumors in the lung
Supplementary Material for "A Single Arm Phase 2 Study of Talimogene Laherparepvec in Patients With Lower Risk Invasive Cutaneous Squamous Cell Cancer" in Journal of the American Academy of Dermatolog
Goal: determine how transcriptome of immune cells within the tumor microenvironment changes as a function of CD40 agonist and/or immune checkpoint blockade (anti-PD-1 AND anti-CTLA-4; "ICB") therapy O
The therapeutic efficacy of whole tumor cell vaccines (TCV) is modest, which has delayed their translation into personalized immunotherapies in the clinic. Here, we developed an innovative and highly
Supplemental Table. Inverse correlation between spike-specific IgG titers and fold-increase in IgG titers in Pfizer-BioNTech and Moderna vaccine recipients, Related to Figures 1 and 2. Raw data are sh